Featured Bioprocessing Editorial
-
7 Focus Areas To Establish A Win-Win Relationship With Your CDMO
1/7/2025
Working with a CDMO doesn’t always go as planned. This article outlines the factors that will impact project success and set up a “win-win” relationship.
-
Deploy AI To Become A cGMP 'Special Agent' With A License To Care
1/7/2025
Addressing systemic cGMP issues requires more than technical fixes — it demands organizational transformation. Thoughtfully applied, AI can empower professionals to become "special agents" of quality, equipped with a "license to care."
-
11 Key Contributing Factors For Maintaining Sterility Assurance
1/6/2025
Containers and closures, depyrogenation, equipment, materials, personnel, and 7 more major factors all contribute to sterility assurance.
-
Here's Why The Life Sciences Struggle To Exploit Process Knowledge
1/2/2025
Pharma often fails to take full advantage of the vast amounts of data it produces. It could do better with knowledge management embedded as a core business strategy.
-
ASTM International Pharmaceutical Cleaning Standards: Current Status And Future Direction
1/2/2025
This article provides an update on the progress of the science-, risk-, and statistics-based ASTM International Cleaning Standards: published standards, work currently underway, and how you can get involved.
-
December 2024 — CDMO Opportunities And Threats Report
1/2/2025
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.
-
Go From Batch To Continuous RNA Purification With mAb Equipment And QBD
12/30/2024
University of Sheffield researchers developed a novel method purify polyadenylated mRNA continuously, which stands to improve productivity and efficiency.
-
Will FDA Finally Enforce DSCSA Interoperability In 2025?
12/26/2024
Two experts weigh in on the persistent problems surrounding the Drug Supply Chain Security Act and its upcoming enforcement deadlines.
-
How Do We Best Meet Future AAV Production Challenges?
12/20/2024
In the recent past, viral vector manufacturers feared a capacity crunch. Now, with vastly improved productivity, predicting demand is a challenge.
-
5 Benefits Of Using MES For Cell & Gene Therapies
12/20/2024
Cell and gene therapies have unique complexities and challenges. A manufacturing execution system (MES) can expedite your processes and get your product to commercialization faster.